[{"Assets_0_Q1_USD":34834000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":0.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":1.05,"EarningsPerShareDiluted_1_Q1_USD":1.04,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1390000000.0,"NetIncomeLossConverted_1_Q1_USD":1710000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q1_USD":5920000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":15317000000.0,"StockholdersEquity_0_Q1_USD":15218000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1637000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1634000000.0,"filed":"20190425","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"BRISTOL MYERS SQUIBB CO","period":"20190331","qtrs":"0","uom":"USD"}]